OCTIMET Oncology
3 known investors
Find your way into OCTIMET Oncology
Sign up to see every warm intro you have to OCTIMET Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OCTIMET Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Developing highly selective MET kinase inhibitors (Beerse, Belgium).
Investors · 3
Droia Ventureslisted by Droia VenturesLuxembourg · $540K
How we know: Droia Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Omnes CapitalreportedParis
How we know: funding news · Not right? Tell us
V-Bio VenturesreportedGhent · $270K – $2.2M
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
In the news
Frequently asked questions
- What does OCTIMET Oncology do?
- Developing highly selective MET kinase inhibitors (Beerse, Belgium).
- Who are OCTIMET Oncology's investors?
- OCTIMET Oncology's investors include Droia Ventures, Omnes Capital, V-Bio Ventures.

